Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year – most of them African children under five.
Amylyx’s Relvyvrio data was, as promised, disappointing
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. So the GLP-1s strike